In these statements, FDA and HHS officials explain that they are initiating a process to schedule concentrated 7OH products as an illicit substance. At the same time, they clearly state that *natural Kratom leaf is not the focus of this action.* They emphasize that their concern is centered on concentrated 7OH products, which they describe as fundamentally different from the Kratom plant that has been used for centuries.
Throughout this video, FDA Commissioner Dr. Marty Makary explains why he believes it’s critical, from a regulatory and public-health standpoint, to distinguish between natural Kratom and concentrated 7OH products, and why lumping everything together creates confusion for consumers, parents, and the public.
This video is presented for educational and informational purposes, using the officials’ own words so viewers can hear directly what is being said, without headlines, assumptions, or added spin. The goal is clarity and understanding of what the FDA is saying, and just as importantly, what they are not saying.
